Pfizer CEO granted 911 phantom stock units

Pfizer Inc. Chairman & CEO Albert Bourla received a grant of phantom stock units under a deferred compensation plan.

Rhea-AI Filing Summary

Pfizer Inc. Chairman & CEO Albert Bourla received a grant of phantom stock units under a deferred compensation plan. On this Form 4, he acquired 911 phantom stock units linked to Pfizer common stock at a reference price of $27.11 per unit. Each unit represents one phantom share of common stock and is settled in cash, not actual shares, after his separation from service. Following this award, Bourla holds a total of 760,090 phantom stock units, reflecting deferred, cash-settled compensation rather than open-market share purchases or sales.

Insider Trade Summary

Grant/Award: 911 shares

Grant/Award 1 txn

Insider BOURLA ALBERT

Role Chairman & CEO

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units SSP	911	$27.11	$25K

Holdings After Transaction: Phantom Stock Units SSP — 760,090 contracts (Direct)

Footnotes (2)

1. F1. Each unit represents one phantom share of common stock.
2. F2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Key Figures

Phantom stock units granted: 911 units Reference price per unit: $27.11 per unit Total phantom units after grant: 760,090 units +1 more

4 metrics

Phantom stock units granted 911 units Grant under Nonfunded Deferred Compensation and Supplemental Savings Plan

Reference price per unit $27.11 per unit Transaction price for 911 phantom stock units

Total phantom units after grant 760,090 units Phantom stock units held following the transaction

Conversion price $0.00 Conversion or exercise price for the phantom stock units

Key Terms

Phantom Stock Units SSP, Nonfunded Deferred Compensation and Supplemental Savings Plan, phantom share of common stock, separation from service

4 terms

Phantom Stock Units SSP financial

"security_title: "Phantom Stock Units SSP""

Nonfunded Deferred Compensation and Supplemental Savings Plan financial

"acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan"

phantom share of common stock financial

"Each unit represents one phantom share of common stock."

separation from service financial

"are settled in cash following the reporting person's separation from service"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Pfizer (PFE) report for Albert Bourla?

Pfizer reported that Chairman & CEO Albert Bourla acquired 911 phantom stock units. These units are a form of deferred compensation tied to Pfizer’s common stock value and are settled in cash after his separation from service, not through open-market stock purchases.

How many phantom stock units does Albert Bourla hold after this Form 4?

After the reported transaction, Albert Bourla holds 760,090 phantom stock units. This total reflects his accumulated deferred compensation balance under Pfizer’s plan, all of which will be settled in cash following his eventual separation from service.

What are Pfizer (PFE) Phantom Stock Units SSP reported in this filing?

Phantom Stock Units SSP are cash-settled units that mirror Pfizer’s common stock value. Each unit represents one phantom share, granting economic exposure without actual share issuance, and they are typically paid out in cash when the executive leaves the company.

Was this Pfizer (PFE) Form 4 a stock purchase or sale by Albert Bourla?

This Form 4 reflects a grant or award acquisition of phantom stock units, not an open-market stock purchase or sale. The 911 units were credited under Pfizer’s nonfunded deferred compensation and supplemental savings plan as part of his compensation.

How and when will Albert Bourla’s Pfizer phantom stock units be settled?

Albert Bourla’s phantom stock units will be settled in cash after his separation from service. Under the Pfizer Nonfunded Deferred Compensation and Supplemental Savings Plan, he may also transfer these units into an alternative investment account at any time before settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/16/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOURLA ALBERT

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units SSP	(1)	04/14/2026		A		911		(2)	(2)	Common Stock	911	$27.11	760,090	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

	/s/ Shanice A. Reid, by Power of atty, for Dennis P. Hancock	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)